Updated on 29 August 2026
SupraOS: The System That Owns Commercial Results
Global CEO at Hylman Group
France
About
Enterprise systems record their part of a commercial result. They do not own whether the result actually happened. Work can be marked complete while the renewal, expansion, deal, collection or customer commitment remains unresolved.
SupraOS is the persistent company-level system that owns the result until reality proves completion. It coordinates many simultaneous outcomes across accounts, products, entities, regions, contracts and time. It keeps each outcome exact while determining which actions can safely happen together, allocating shared people and authority, executing, independently proving what changed, confirming the result held and measuring the value caused.
Every completed run creates a verified record of what was true, what action was taken, what changed and what result followed. SupraOS uses those records to make stronger decisions across the company with less human intervention.
Traction since April 2026: 10 customers, US$868k sales, US$1.72M in confirmed customer value from the first 4 deployments with 6.4x payback within 8 weeks, 84% gross margin and a 21-day median sales cycle. Gold (1st place) Tech Startup of the Year in Software 2026 by Stevie Awards. Founder Hassan Al-Shama had 2 prior exits, led AI at Grant Thornton and Strategy at Airbus Defence, and built Hylman to US$7M/yr across 16 countries without external capital. Top Consultant 2026 by Consulting Magazine.
SupraOS is raising a US$4M seed round to scale. We are seeking investors in enterprise software, AI and category-defining companies.
Project Location
- China (Hong Kong)
Project Website
https://supraos.co
Project Format
- Private Project
Go Global Project
- Yes
ESG (Environmental, Social, and Governance)
- Yes
Project Stage
- Operations
Main Project Sector
- Technology
Technology
- E-Business
Total Project Value
- 25,000,001 to 50,000,000 USD
Investment Capital Required
- 2,500,001 to 5,000,000 USD
Interested Format of Cooperation
- Convertible Loan
- Direct Equity Investment
- Minority Shareholdings
- Joint Venture
- Open for Negotiation
Preferred Financing Model
- Equity
- Open for negotiation
Type(s) of Last Financing Round of the project (if Applicable)
- Bootstrapping
Main Service(s) Required
- Financial Services
Financial Services
- Investment Banking
- Private Equity & Venture Capital
- Trust Fund
- Wealth Management
Attached files
Organisation
France
Similar opportunities
Project
Project for Potential Osteoarthritis Global Player
- No
- Yes
- Equity
- Bio-Tech
- Technology
- Bootstrapping
- Private Project
- Financial Services
- Open for negotiation
- Open for Negotiation
- 50,000,001 USD or above
- Direct Equity Investment
- 25,000,001 to 50,000,000 USD
- Private Equity & Venture Capital
- Investment / Financing Discussion
Seungtaek NA
CEO at StarryBio
South Korea
Project
Aden OTC Assets Electronic Trading Platform
- No
- Yes
- Equity
- Fin-Tech
- Technology
- Securities
- Private Project
- Equity (private)
- Wealth Management
- Financial Services
- Minority Shareholdings
- 50,000,001 USD or above
- Direct Equity Investment
- 25,000,001 to 50,000,000 USD
- Investment / Financing Discussion
CHENG CHEN
Co-Founder at ADEN GROUP
China (Hong Kong)
Project
- Yes
- Yes
- Technology
- Bootstrapping
- Private Project
- Financial Services
- Property Technology
- 500,000 USD or Below
- 500,001 to 1,000,000 USD
- Direct Equity Investment
- Private Equity & Venture Capital
- Investment / Financing Discussion
Frankie Chiu
Chief Commercial Officer at Sharp Peak Consulting Limited
China (Hong Kong)